For patients with HFpEF, medical therapy options now abound

Carlos Santos-Gallego

Icahn School of Medicine at Mount Sinai

Press/Media

Period	20 Oct 2021

Media coverage

1

Media coverage

Title	For patients with HFpEF, medical therapy options now abound
Media name/outlet	Healio
Country/Territory	United States
Date	20/10/21
URL	https://www.healio.com/news/cardiology/20211012/for-patients-with-hfpef-medical-therapy-options-now-abound
Persons	Carlos Santos-Gallego

Related content

Research Output
Mechanistic Insights of Empagliflozin in Nondiabetic Patients With HFrEF: From the EMPA-TROPISM Study
Research output: Contribution to journal › Article › peer-review
Empagliflozin Ameliorates Adverse Left Ventricular Remodeling in Nondiabetic Heart Failure by Enhancing Myocardial Energetics
Research output: Contribution to journal › Article › peer-review